SC Filed 2021-09-27 Event — SEC 0000902664-21-004358 →

HHLR ADVISORS, LTD. → I-Mab NBP

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +5.3%

Passive Schedule 13G filer baseline
Elevated short days-to-cover (10.6 DTC)
Short interest building (+12.7% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

0 buys · 1 sales · 2 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

16 filings by this filer

15 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 10.58

3,700,826 shares short · +12.7% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-06	Xu Cong Claire	officer	Sale	4,485	$0.89	$4K
2026-07-04	Xu Cong Claire	officer	Option exercise	12,432	—	—
2026-07-04	Xu Cong Claire	officer	Option exercise	5,405	—	—

Other 13D/G Filings on I-Mab

Filed	Form	Filer	Stake	Shares
2021-06-24	SC	HILLHOUSE CAPITAL ADVISORS, LTD.	—	—	view →
2021-03-25	SC	HILLHOUSE CAPITAL ADVISORS, LTD.	—	—	view →
2020-12-21	SC	HILLHOUSE CAPITAL ADVISORS, LTD.	—	—	view →

Other Filings by HHLR ADVISORS, LTD.

Filed	Form	Issuer	Stake	Shares
2025-03-03	SCHEDULE	BeiGene, Ltd. BEIGF	6.70%	92,805,741	view →
2021-07-19	SC	Enstar Group LTD	—	—	view →
2021-06-24	SC	I-Mab NBP	—	—	view →
2021-04-22	SC	China Biologic Products Holdings, Inc.	—	—	view →
2021-03-25	SC	I-Mab NBP	—	—	view →
2020-12-21	SC	I-Mab NBP	—	—	view →
2020-11-23	SC	China Biologic Products Holdings, Inc.	—	—	view →
2020-10-28	SC	China Biologic Products Holdings, Inc.	—	—	view →
2020-06-24	SC	Cellular Biomedicine Group, Inc.	—	—	view →
2020-03-30	SC	Cellular Biomedicine Group, Inc.	—	—	view →
2020-02-21	SC	Cellular Biomedicine Group, Inc.	—	—	view →
2020-01-30	SC	Cellular Biomedicine Group, Inc.	—	—	view →
2020-01-27	SC	China Biologic Products Holdings, Inc.	—	—	view →
2019-04-02	SC	Enstar Group LTD	—	—	view →
2019-01-03	SC	BeiGene, Ltd. BEIGF	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →